文献速递生殖医学

青春期晚期的代谢综合征特征与20岁时睾丸功能受损相关

Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age.
PubMed 文献 · Hum Reprod · 2019-01-01

基于西澳大利亚妊娠队列(Raine)研究,17岁时具有代谢紊乱特征的男性在20岁时表现出睾丸功能受损和激素水平改变;17岁时有非酒精性脂肪性肝病者精子输出中位数降低近50%,20岁时存在胰岛素抵抗者睾丸体积减少20%。

要点

  • 17岁时代谢高危组男性血清睾酮和抑制素B中位数低于低危组。
  • 17岁有非酒精性脂肪性肝病者20岁时精子输出和睾酮中位数降低。
  • 20岁时胰岛素抵抗(HOMA>4)与睾酮、抑制素B降低及FSH升高相关。

核心结论

  • 17岁时具有代谢紊乱特征或20岁时存在胰岛素抵抗的青少年,与无代谢紊乱者相比,表现出睾丸功能受损和激素水平改变。

研究设计与样本

  • 西澳大利亚妊娠队列(Raine)研究为纵向研究,纳入1989-1991年出生的儿童,出生男婴1454例。
  • 17岁时490名男孩接受肝脏超声检查,520名接受血清细胞因子评估,544名接受代谢评估;20岁时608名接受代谢评估。
  • 20岁时进行睾丸评估:609名测量生殖激素,404名接受睾丸超声,365名提供精液样本。

主要发现

  • 17岁代谢高危组男性血清睾酮中位数为4.0 ng/mL vs 低危组4.9 ng/mL,抑制素B中位数为193.2 pg/mL vs 低危组221.9 pg/mL(两者P<0.001)。
  • 17岁有非酒精性脂肪性肝病(n=45,9.8%)者20岁时总精子输出中位数为68.0百万 vs 无NAFLD者126.00百万(P=0.044),睾酮中位数4.0 ng/mL vs 4.7 ng/mL(P=0.005),抑制素B中位数209.1 pg/mL vs 218.4 pg/mL(P=0.032)。
  • 17岁时可溶性肿瘤坏死因子受体1浓度较高者精子输出和血清抑制素B较低,LH和FSH升高(校正年龄、BMI、禁欲时间、隐睾史、精索静脉曲张、吸烟、饮酒和药物使用后均P<0.05)。
  • 多变量回归分析校正混杂因素后,20岁时代谢高危组男性血清睾酮和抑制素B较低(P=0.003和P=0.001)。
  • HOMA-IR>4与血清睾酮较低(P<0.001)、抑制素B较低(P=0.010)及血清FSH升高(P=0.015)相关。

关键数值与推荐

  • 胰岛素抵抗近似定义为HOMA>4。
  • 采用两步聚类分析,基于腰围、甘油三酯、胰岛素和收缩压推导出代谢综合征高危组。

局限性

  • 本研究受样本量和多重比较限制,观察性研究不能证明因果关系。
  • 由于部分代谢评估与睾丸功能评估间隔3年,不能排除研究引入偏倚,因部分参与者在17岁评估时睾丸功能尚未完全成熟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are early signs of metabolic disorder in late adolescence associated with features of impaired testicular function many years before the majority seek parenthood? SUMMARY ANSWER: Adolescents with features of metabolic disorder at 17 years, or insulin resistance (IR) at 20 years of age, show impaired testicular function and altered hormone levels compared to those without metabolic disorder. WHAT IS KNOWN ALREADY: Controversial evidence suggests a recent decline in sperm production potentially linked to environmental influences, but its cause remains unclear. Concomitant increases in obesity and diabetes suggest that lifestyle factors may contribute to this decline in testicular function. Although obesity has been associated with adverse testicular function in some studies, it remains unclear whether poor testicular function merely reflects, or causes, poor metabolic health. If metabolic disorder were present in adolescence, prior to the onset of obesity, this may suggest that metabolic disorder maybe a precursor of impaired testicular function. STUDY DESIGN, SIZE, DURATION: The Western Australian Pregnancy Cohort (Raine) Study is a longitudinal study of children born in 1989-1991 who have undergone detailed physical assessments since birth (1454 male infants born). At 17 years of age, 490 boys underwent a hepatic ultrasound examination, serum cytokine assessment (n = 520) and a metabolic assessment (n = 544). A further metabolic assessment was performed at 20 years (n = 608). Testicular assessment was performed at 20 years; 609 had reproductive hormones measured, 404 underwent a testicular ultrasound and 365 produced a semen sample. PARTICIPANTS/MATERIALS, SETTING, METHODS: Testicular volume was estimated by ultrasonography, and semen analysis was performed according to World Health Organization guidelines. Concentrations of LH, FSH and inhibin B (inhB) in serum were measured by immunoassay and total testosterone by liquid chromatography-mass spectrometry.At 17 years of age, a liver ultrasound examination was performed to determine the presence of non-alcoholic fatty liver disease (NAFLD), and serum analysed for the cytokines interleukin-18 and soluble tumour necrosis factor receptor 1 and 2 (sTNFR1, sTNFR2).At 17 and 20 years of age, fasting blood samples were analysed for serum liver enzymes, insulin, glucose, triglycerides (TG), total cholesterol, high density lipoprotein and low density lipoprotein cholesterol, high sensitivity C-reactive protein and uric acid. The homoeostatic model assessment (HOMA) was calculated and approximated IR was defined by a HOMA >4. Anthropometric data was collected and dual energy X-ray absorptiometry measurement performed for lean and total fat mass. As at this young age the prevalence of metabolic syndrome was expected to be low, a two-step cluster analysis was used using waist circumference, TGs, insulin, and systolic blood pressure to derive a distinct high-risk group with features consistent with the metabolic syndrome and increased cardiometabolic risk. MAIN RESULTS AND THE ROLE OF CHANCE: Men at age 17 years with increased cardiometabolic risk had lower concentrations of serum testosterone (medians: 4.0 versus 4.9 ng/mL) and inhB (193.2 versus 221.9 pg/mL) (P < 0.001 for both) compared to those within the low risk metabolic cluster. Men with ultrasound evidence of NAFLD (n = 45, 9.8%) had reduced total sperm output (medians: 68.0 versus 126.00 million, P = 0.044), testosterone (4.0 versus 4.7 ng/mL, P = 0.005) and inhB (209.1 versus 218.4 pg/mL, P = 0.032) compared to men without NAFLD.Men with higher concentrations of sTNFR1 at 17 years of age had a lower sperm output and serum concentration of inhB, with an increase in LH and FSH (all P < 0.05 after adjustment for age, BMI, abstinence and a history of cryptorchidism, varicocele, cigarette smoking, alcohol and drug use), compared to those without an elevated sTNFR1. Multivariable regression analysis, adjusting for confounders, demonstrated that men in the high-risk metabolic cluster at 20 years had a lower serum testosterone and inhB (P = 0.003 and P = 0.001, respectively). A HOMA-IR > 4 was associated with a lower serum testosterone (P = <0.001) and inhB (P = 0.010) and an increase in serum FSH (P = 0.015). LIMITATIONS, REASONS FOR CAUTION: This study is limited by the sample size and multiple comparisons, and causality cannot be proven from an observational study. Due to a 3-year interval between some metabolic assessments and assessment of testicular function, we cannot exclude the introduction of a bias into the study, as some of the participants and their testicular function will not have been fully mature at the 17-year assessment. WIDER IMPLICATIONS OF THE FINDINGS: Irrespective of a proven causation, our study findings are important in that a significant minority of the men, prior to seeking parenthood, presented co-existent features of metabolic disorder and signs of testicular impairment. Of particular note is that the presence of NAFLD at 17 years of age, although only present in a minority of men, was associated with an almost 50% reduction in sperm output at 20 years of age, and that the presence of IR at 20 years was associated with a 20% reduction in testicular volume. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by Australian NHMRC (Grant Numbers 634457, 35351417 and 403981) and received support from the Raine Medical Research Foundation, The Telethon Kids Institute, University of Western Australia, Women and Infants Research Foundation, Curtin University and Edith Cowan University. D.A.D., J.E.D., N.M., L.A.A., R.-C.H., T.A.M., J.K.O., L.J.B. have nothing to declare. R.J.H. is Medical Director of Fertility Specialists of Western Australia, has equity interests in Western IVF, and has received grant support from MSD, Merck-Serono and Ferring Pharmaceuticals. RMcL has equity interests in the Monash IVF Group. R.J.N. has equity interests in FertilitySA, and has received grant support from Merck Serono and Ferring Pharmaceuticals. D.J.H. has received institutional grant funding (but no personal income) for investigator-initiated testosterone pharmacology studies from Lawley and Besins Healthcare and has provided expert testimony to anti-doping tribunals and for testosterone litigation.This abstract was awarded the Fertility Society of Australia clinical exchange award for the oral presentation at ESHRE, Barcelona, in 2018.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Hart RJ, Doherty DA, Mori TA, et al. Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age. Hum Reprod. 2019. PMID: 30576537. doi:10.1093/humrep/dey371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。